SCHEMBL22128239

SCHEMBL22128239

CC(C)(C#N)c1cn(CC(CO)CO[Si](C)(C)C(C)(C)C)c2cc(Br)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22128369 0.91
SCHEMBL22128414 0.91
SCHEMBL22128175 0.91
SCHEMBL22122390 0.87 SMN1; SMN2 (0.32)
SCHEMBL22122260 0.87 SMN1; SMN2 (0.35)
SCHEMBL22128381 0.87
SCHEMBL22128251 0.85
SCHEMBL22122373 0.84
SCHEMBL22122269 0.83 SMN1; SMN2 (0.33)
SCHEMBL22122325 0.83 SMN1; SMN2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240139185-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2024-05-02 US disclosed
CN-113498342-A Compounds involved in synergistic binding and uses thereof 锐新医药公司 2021-10-12 CN disclosed
US-20200197391-A1 COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF Revolution Medicines, Inc. 2020-06-25 US disclosed